FDA wary of deaths with Pfizer osteoporosis drug Federal regulators say a drug from Pfizer and Ligand Pharmaceuticals effectively treats osteoporosis, though they are concerned about deaths, blood clots and other problems seen in company studies. 04 Sep 2008
2.
Medivation jumps to all-time high on Pfizer pact Shares of Medivation Inc. climbed to an all-time high Wednesday after the company struck a marketing agreement with Pfizer Inc. for the Alzheimer's disease and Huntington's disease drug candidate Dimebon. 03 Sep 2008
3.
Hershey names former Pfizer exec to its board Hershey Co. said late Tuesday it has elected a former vice chairman of Pfizer, David Shedlarz, to its board on Aug. 29. Shedlarz was a member of the executive leadership team and vice chairman of the pharmaceutical company until 2007, when he retired. He first joined Pfizer in 1976 and served in various roles, including that of chief financial officer. 03 Sep 2008
4.
Pfizer and Medivation to partner on Dimebon Pfizer Inc. and Medivation Inc. on Wednesday entered a partnership to develop and promote Medivation's Dimebon, a drug candidate designed to treat Alzheimer's disease and Huntington's disease. 03 Sep 2008
5.
Study: Pfizer, Bristol-Myers drug boosts bleeding Pfizer Inc. and Bristol-Myers Squibb Co. said Tuesday a midstage safety study showed their experimental blood thinner apixaban did increase patients' risk of bleeding, but may also reduce patients' risk of a second heart attack, stroke or death. 02 Sep 2008
6.
Pfizer resuming ads for Lipitor after controversy Television ads for the world's top-selling drug, cholesterol fighter Lipitor, are back, six months after Pfizer Inc. pulled them amid charges its use of a celebrity doctor endorser who's never practiced medicine misled the public. 02 Sep 2008
7.
Pfizer wins patent dispute over Lipitor in Denmark Pfizer Inc. said Friday a court in Denmark has blocked Ranbaxy Laboratories from launching a generic version of the blockbuster cholesterol drug Lipitor in that country. 29 Aug 2008
8.
Schering-Plough: EU OKs product sale to Pfizer U.S. drug maker Schering-Plough Corp. won EU approval Wednesday to sell off several animal vaccines and medicines to rival Pfizer Corp., obeying an earlier EU antitrust order to offload some assets before it could buy another pharmaceutical business. 27 Aug 2008
9.
New type of anti-clotting drug misses testing goal A new type of blood thinner being developed by two top pharmaceutical companies didn't meet its goal in a late-stage test of its ability to prevent certain dangerous blood clots, but research for other uses will continue, the companies said late Tuesday. 26 Aug 2008
10.
Pfizer biotech unit plans San Francisco relocation San Francisco Mayor Gavin Newsom has announced that Pfizer Inc. will relocate its biotech research center to the city, a move leaders hope will attract other biomedical businesses. 06 Aug 2008
0.44%SPY 123.80 
1.14%
